Lazarus M

Open-Label Pilot Study of Alitretinoin Gel 0.1% in the Treatment of Photoaging

Publish date: July 1, 2005

Alitretinoin (9-cis-retinoic acid) is an FDA-approved topical therapy for the treatment of Kaposi sarcoma.